New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
Cervarix, a cervical cancer vaccine produced by Glaxo Smithkline (Britain's biggest drug manufacturer) is being registered for approval// by the European regulatory authority. If approved, the vaccine would be marketed for commercial use, by the end of next year. Gardasil, a similar vaccine ...PDL BioPharma Elects Barry Selick to Its Board of Directors
...chnology company Camitro Corporation. From 1992 to 1999, he worked at Affymax Research Institute, the drug discovery technology development center for glaxo Wellcome plc, most recently as vice president of Research. Prior to joining Affymax, he held scientific positions at Protein Design Labs, Inc. and Ane...Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning
...ffairs and hundreds of U.S. hospitals, including Mayo, Columbia Presbyterian, the Cleveland Clinic and Bethesda Naval Hospital. Pharmas such as Roche, glaxo Smithkline and Ortho Biotech have distributed over half a million CDs to Chemotherapy and Radiation patients around the English speaking world, and th...Prasco Selected as GSK's Generics Marketing and Distribution Agent
...perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older. FLONASE(R) is a registered trademark of glaxo Group Limited, UK. About Prasco Prasco's mission is to provide both quality products and significant cost-savings to the consumer. Prasco's...New Genetic Links to Baldness Discovered
...ne to prevent hair loss in people with the gene variants is another story, Brockschmidt acknowledged. One of the new studies was financed, in part, by glaxo SmithKline, a pharmaceutical company that might seek commercial benefit from its support. And one small company already markets a $149 genetic screeni...Senetek PLC Announces Key Personnel Appointments
...ational pharmaceutical research, development and sales and marketing organizations. For nine years, Mr. Rose was Vice President of Corporate Sales for glaxo Pharmaceuticals, Inc. In 1997 he became Vice President and General Manager of North American Operations for ICN Pharmaceuticals, Inc. (now Valeant Pha...Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
... 2000, Dr. Knight served as Director of Molecular Biochemistry in the Biochemistry Division of Glaxo-Wellcome. He also held several positions with the glaxo Research Institute/Glaxo, Inc. from 1992-1995, later becoming head of the Dept. of Biochemistry and Protein Engineering in the Division of Molecular S...Tamoxifen-like drug suggests new ways to selectively block estrogen
...40 to 50 in progress." GW5638 was developed as a variation on tamoxifen in the early 1990s by co-author Tim Willson and colleagues at what was then glaxo Wellcome, hence the name GW5638. McDonnell, at Duke, recognized its potential and demonstrated efficacy in animal models of tamoxifen-resistant breast...Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
...was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline Beecham with glaxo Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development. Dr. Greig also serves on the boar...Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
...iologics, and China is a critical component of our strategy at aTyr," said Dr. Schimmel. "Similar to our efforts at Sirtris Pharma, which was sold to glaxo Smith Kline for $720M in 2008, we will leverage operations in Hong Kong to effectively and efficiently discover and characterize new compositions. Ba...GeneNews announces management changes
... National Sales Manager and, prior to that, Government Relations and Reimbursement Manager. Prior to his tenure at Medtronic, he spent nine years with glaxo Canada (now GSK) with responsibility for a number of pharmaceutical products. Mr.Young is the former Director of Corporate Compliance for OccuLogix....Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences
...erienced biotechnology and pharmaceutical executive, currently serving as Lead Director of Genentech. He has also served as chief executive officer of glaxo Inc., from 1989-1994 and chairman of the board from 1992-1995. In addition, Dr. Sanders is also a member of the Boards of Directors of Vertex Pharmace...CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
...than 150 percent to euro 2.5 billion in 2007. Global pharmaceutical companies such as AstraZeneca, Bristol Meyers Squibb, Daiichi Sankyo, Eli Lilly, glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, and Pfizer have selected Menarini to sell some of their most important brands in Europe, including at...Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
...ployee that Mr. Campbell hired upon founding the firm. "My relationship with Nader dates back more than 14 years to when we first worked together at glaxo [now GlaxoSmithKline]. I have depended on him as my friend and trusted business advisor since that time. I'm proud to appoint him to this new senior e...Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
...xecutive management team, on a part-time basis during this year, to provide scientific leadership and guidance. He has held global leadership roles at glaxo Wellcome and Burroughs Wellcome and in recent years, at Valeant Pharmaceuticals International and Anadys Pharmaceuticals, Inc, a company he co-founded...